Pyruvate Kinase M2 (PKM2) is an oncofetal isoform generated as a result of alternative splicing of the PKM mRNA transcript exhibit low basal activity and thus is a key player in regulating the glycolytic flux contributing to cancer progression [3–6]. The gene discussed is PKM; the disease is cancer.